University Hospital Essen
Essen, Germany
18 recruiting
Showing 1–20 of 30 trials
Recruiting
Phase 2
A Phase II Trial of Teclistamab in Participants With Previously Treated Immunoglobulin Light-chain (AL) Amyloidosis
AL Amyloidosis
European Myeloma Network B.V.30 enrolled10 locationsNCT06649695
Recruiting
Phase 1Phase 2
Anti-tumour Activity of (177Lu) rhPSMA-10.1 Injection
Prostate CancerMetastatic Castration-resistant Prostate CancerUrogenital Neoplasms+3 more
Blue Earth Therapeutics Ltd82 enrolled23 locationsNCT05413850
Recruiting
Mental Health and Suicidality in Glioblastoma Patients in Germany
Glioblastoma (GBM)
University Hospital, Essen176 enrolled6 locationsNCT07409584
Recruiting
The Head and Neck Registry of the European Reference Network on Rare Adult Solid Cancers
Head and Neck CancerSalivary Gland CancerNasopharynx Cancer+2 more
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano13,600 enrolled10 locationsNCT05483374
Recruiting
Not Applicable
Reducing Symptom Burden Through Physical Exercise in Melanoma Patients
Malignant Melanoma
Universität Duisburg-Essen104 enrolled1 locationNCT06985056
Recruiting
Phase 3
A Study of Pitolisant in Patients With Prader-Willi Syndrome
Prader-Willi Syndrome
Harmony Biosciences Management, Inc.134 enrolled54 locationsNCT06366464
Recruiting
PROCARE - PROstate Cancer Real World Evidence Registry
Prostate CancerMetastatic Castration-resistant Prostate CancerMetastatic Hormone-Sensitive Prostate Cancer (mHSPC)+2 more
UroTrials Company (GmbH)5,000 enrolled53 locationsNCT06835218
Recruiting
German Dementia Registry
Dementia Disorder
RWTH Aachen University5,000 enrolled24 locationsNCT07433010
Recruiting
Outcomes of Low-Risk Endometrial Cancer With Isolated Tumor Cells in the Sentinel Lymph Nodes: A Prospective, Multicenter, Single-Arm Observational Study
FIGO Grade 1 Endometrial Endometrioid AdenocarcinomaFIGO Grade 2 Endometrial Endometrioid AdenocarcinomaStage IA1 Endometrial Cancer FIGO 2023+1 more
Mayo Clinic212 enrolled20 locationsNCT06689956
Recruiting
A Study of Trastuzumab DeRuxtecan for Patients With Advanced HER2-pOsitive GaStric or GastroesoPhageal Junction AdEnocarcinoma Who Have Received a PrIor Trastuzumab-based Regimen Accompanied by a Disease RegistrY of Patients Treated With Conventional Therapies (PROSPERITY)
HER2-positive Advanced Gastric CancerHER2-positive Gastroesophageal Junction Adenocarcinoma
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company257 enrolled76 locationsNCT05993234
Recruiting
CATCH: Implementation of Genomics-guided Precision Medicine in Metastatic Breast Cancer
Metastatic Breast Cancer
German Cancer Research Center5,000 enrolled12 locationsNCT05652569
Recruiting
Quality of Life and Medical Care of Long-term Sarcoma Survivors in Germany (PROSa+)
Quality of Life (QOL)SarcomaSurvivorship+1 more
Technische Universität Dresden1,600 enrolled5 locationsNCT07148193
Recruiting
International HIT-MED Registry (I-HIT-MED)
Childhood Brain Tumor
Universitätsklinikum Hamburg-Eppendorf500 enrolled57 locationsNCT02417324
Recruiting
Efficacy, Safety & Utilisation of Nuwiq, Octanate and Wilate in Previously Untreated & Minimally Treated Haemophilia A Patients
Haemophilia A
Octapharma200 enrolled55 locationsNCT03695978
Recruiting
European Newborn Study: Early Markers for a Better LifE
Cerebral Palsy
dr. M.J.N.L. Benders1,000 enrolled8 locationsNCT07189494
Recruiting
The FOrMe Registry (The German Focal Segmental Glomerulosclerosis and Minimal Change Disease Registry)
Minimal Change DiseaseGlomerulosclerosis, Focal SegmentalIdiopathic Nephrotic Syndrome
Prof. Dr. Paul Brinkkoetter500 enrolled12 locationsNCT03949972
Recruiting
Cardiac Amyloid Deposits and Heart Dysfunction in Alzheimer's Disease
Mild Cognitive ImpairmentCardiac AmyloidosisDementia Alzheimer Type
University Hospital, Essen15 enrolled1 locationNCT07154394
Recruiting
TTFields in General Routine Clinical Care in Patients With Pleural Mesothelioma Study
Pleural Mesothelioma
NovoCure Ltd.198 enrolled23 locationsNCT05538806
Recruiting
Essen Amyloidosis Registry
Amyloidosis CardiacAmyloidosis; Systemic
University Hospital, Essen400 enrolled1 locationNCT06887283
Recruiting
Phase 2
Fecal Microbiota Transfer in Liver Cancer to Overcome Resistance to Atezolizumab/Bevacizumab (FLORA)
ImmunotherapyHCC - Hepatocellular Carcinoma
Michael Dill48 enrolled7 locationsNCT05690048